Your browser doesn't support javascript.
loading
Inhibition of epidermal growth factor receptor improves antitumor efficacy of vemurafenib in BRAF-mutant human melanoma in preclinical model.
Kenessey, István; Kramer, Zsófia; István, Lilla; Cserepes, Mihály T; Garay, Tamás; Hegedus, Balázs; Dobos, Judit; Tímár, József; Tóvári, József.
Afiliación
  • Kenessey I; 2nd Department of Pathology, Semmelweis University.
  • Kramer Z; Hungarian Cancer Registry, National Institute of Oncology.
  • István L; 2nd Department of Pathology, Semmelweis University.
  • Cserepes MT; 2nd Department of Pathology, Semmelweis University.
  • Garay T; Department of Experimental Pharmacology, National Institute of Oncology.
  • Hegedus B; Institute of Enzymology, Research Center for Natural Sciences, Hungarian Academy of Sciences.
  • Dobos J; Semmelweis University.
  • Tímár J; 2nd Department of Pathology, Semmelweis University.
  • Tóvári J; Hungarian Academy of Sciences, Molecular Oncology Research Group, Semmelweis University.
Melanoma Res ; 28(6): 536-546, 2018 12.
Article en En | MEDLINE | ID: mdl-30124539
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores ErbB / Vemurafenib / Melanoma / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Melanoma Res Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores ErbB / Vemurafenib / Melanoma / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Melanoma Res Asunto de la revista: NEOPLASIAS Año: 2018 Tipo del documento: Article